Palmitoyl acyltransferase assays and inhibitors (Review)

Molecular Membrane Biology

Volumn 26, Issue 1-2, 2009, Pages 5-13

  Draper, Jeremiah M ^a   Smith, Charles D ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

2 bromopalmitate; Cerulenin; Inhibitor; Palmitoyl acyltransferase; Tunicamycin

Indexed keywords

ACYLTRANSFERASE; AZIDE; FATTY ACID; PALMITIC ACID; PALMITOYL ACYLTRANSFERASE; UNCLASSIFIED DRUG;

ENZYME ASSAY; FATTY ACID SYNTHESIS; IN VITRO STUDY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR RECOGNITION; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN MOTIF; REVIEW;

ACYLTRANSFERASES; DRUG DISCOVERY; ENZYME INHIBITORS; HUMANS; LIPOYLATION;

EID: 61449170090     PISSN: 09687688     EISSN: 14645203     Source Type: Journal    
DOI: 10.1080/09687680802683839     Document Type: Review

References (47)

1. Huang K, Yanai A, Kang R, Arstikaitis P, Singaraja RR, Metzler M, Mullard A, Haigh B, Gauthier-Campbell C, Gutekunst CA, Hayden MR, El-Husseini A. 2004. Huntingtin-interacting protein HIP14 is a palmitoyl transferase involved in palmitoylation and trafficking of multiple neuronal proteins. Neuron 44:977-986.
2. Garcia-Cardena G, Oh P, Liu J, Schnitzer JE, Sessa WC. 1996. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci USA 93:6448-6453.
3. Liu L, Dudler T, Gelb MH. 1996. Purification of a protein palmitoyltransferase that acts on H-Ras protein and on a C-terminal N-Ras peptide. J Biol Chem 271:23269-23276.
4. Kawashima S, Yokoyama M. 2004. Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol 24:998-1005.
5. Ortiz PA, Garvin JL. 2003. Cardiovascular and renal control in NOS-deficient mouse models. Am J Physiol Regul Integr Comp Physiol 284:R628-638.
6. Kosugi A, Hayashi F, Liddicoat DR, Yasuda K, Saitoh S, Hamaoka T. 2001. A pivotal role of cysteine 3 of Lck tyrosine kinase for localization to glycolipid-enriched microdomains and T cell activation. Immunol Lett 76:133-138.
7. Prior IA, Harding A, Yan J, Sluimer J, Parton RG, Hancock JF. 2001. GTP-dependent segregation of H-ras from lipid rafts is required for biological activity. Nat Cell Biol 3:368-375.
8. Pecquet C, Nyga R, Penard-Lacronique V, Smithgall TE, Murakami H, Regnier A, Lassoued K, Gouilleux F. 2007. The Src tyrosine kinase Hck is required for Tel-Abl- but not for Tel-Jak2-induced cell transformation. Oncogene 26:1577-1585.
9. Ducker CE, Stettler EM, French KJ, Upson JJ, Smith CD. 2004. Huntingtin interacting protein 14 is an oncogenic human protein: palmitoyl acyltransferase. Oncogene 23:9230-9237.
10. Lobo S, Greentree WK, Linder ME, Deschenes RJ. 2002. Identification of a Ras palmitoyltransferase in Saccharomyces cerevisiae. J Biol Chem 277:41268-41273.
11. Roth AF, Feng Y, Chen L, Davis NG. 2002. The yeast DHHC cysteine-rich domain protein Akr1p is a palmitoyl transferase. J Cell Biol 159:23-28.
12. Ohno Y, Kihara A, Sano T, Igarashi Y. 2006. Intracellular localization and tissue-specific distribution of human and yeast DHHC cysteine-rich domain-containing proteins. Biochim Biophys Acta 1761:474-483.
13. Sharma C, Yang XH, Hemler ME. 2008. DHHC2 affects palmitoylation, stability, and functions of Tetraspanins CD9 and CD151. Mol Biol Cell 19:3415-3425.
14. Swarthout JT, Lobo S, Farh L, Croke MR, Greentree WK, Deschenes RJ, Linder ME. 2005. DHHC9 and GCP16 constitute a human protein fatty acyltransferase with specificity for H- and N-Ras. J Biol Chem 280:31141-31148.
15. Resh MD. 2006. Palmitoylation of ligands, receptors, and intracellular signaling molecules. Sci STKE 2006:re14.
16. Drisdel RC, Alexander JK, Sayeed A, Green WN. 2006. Assays of protein palmitoylation. Methods 40:127-134.
17. Fernandez-Hernando C, Fukata M, Bernatchez PN, Fukata Y, Lin MI, Bredt DS, Sessa WC. 2006. Identification of Golgi-localized acyl transferases that palmitoylate and regulate endothelial nitric oxide synthase. J Cell Biol 174:369-377.
18. Fukata M, Fukata Y, Adesnik H, Nicoll RA, Bredt DS. 2004. Identification of PSD-95 palmitoylating enzymes. Neuron 44:987-996.
19. Berthiaume L, Peseckis SM, Resh MD. 1995. Synthesis and use of iodo-fatty acid analogs. Methods Enzymol 250:454-466.
20. Peseckis SM, Deichaite I, Resh MD. 1993. Iodinated fatty acids as probes for myristate processing and function. Incorporation into pp60v-src. J Biol Chem 268:5107-5114.
21. Hensel J, Hintz M, Karas M, Linder D, Stahl B, Geyer R. 1995. Localization of the palmitoylation site in the transmembrane protein p12E of Friend murine leukaemia virus. Eur J Biochem 232:373-380.
22. Liang X, Nazarian A, Erdjument-Bromage H, BornmannW, Tempst P, Resh MD. 2001. Heterogeneous fatty acylation of Src family kinases with polyunsaturated fatty acids regulates raft localization and signal transduction. J Biol Chem 276:30987-30994.
23. Hang HC, Geutjes EJ, Grotenbreg G, Pollington AM, Bijlmakers MJ, Ploegh HL. 2007. Chemical probes for the rapid detection of Fatty-acylated proteins in Mammalian cells. J Am Chem Soc 129:2744-2745.
24. Draper JM, Xia Z, Smith CD. 2007. Cellular palmitoylation and trafficking of lipidated peptides. J Lipid Res 48:1873-1884.
25. James GL, Goldstein JL, Brown MS, Rawson TE, Somers TC, McDowell RS, Crowley CW, Lucas BK, Levinson AD, Marsters JCJr. 1993. Benzodiazepine peptidomimetics: potent inhibitors of Ras farnesylation in animal cells. Science 260:1937-1942.
26. Pompliano DL, Rands E, Schaber MD, Mosser SD, Anthony NJ, Gibbs JB. 1992. Steady-state kinetic mechanism of Ras farnesyl: protein transferase. Biochemistry 31:3800-3807.
27. Chen WJ, Andres DA, Goldstein JL, Russell DW, Brown MS. 1991. cDNA cloning and expression of the peptide-binding beta subunit of rat p21ras farnesyltransferase, the counterpart of yeast DPR1/RAM1. Cell 66:327-334.
28. Kohl NE, Mosser SD, deSolms SJ, Giuliani EA, Pompliano DL, Graham SL, Smith RL, Scolnick EM, Oliff A, Gibbs JB. 1993. Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science 260:1934-1937.
29. Webb Y, Hermida-Matsumoto L, Resh MD. 2000. Inhibition of protein palmitoylation, raft localization, and T cell signaling by 2-bromopalmitate and polyunsaturated fatty acids. J Biol Chem 275:261-270.
30. Li X, Yang Y, Hu Y, Dang D, Regezi J, Schmidt BL, Atakilit A, Chen B, Ellis D, Ramos DM. 2003. Alphavbeta6-Fyn signaling promotes oral cancer progression. J Biol Chem 278:41646-41653.
31. Chenette EJ, Abo A, Der CJ. 2005. Critical and distinct roles of amino- and carboxyl-terminal sequences in regulation of the biological activity of the Chp atypical Rho GTPase. J Biol Chem 280:13784-13792.
32. Chase JF, Tubbs PK. 1972. Specific inhibition of mitochondrial fatty acid oxidation by 2-bromopalmitate and its coenzyme A and carnitine esters. Biochem J 129:55-65.
33. Coleman RA, Rao P, Fogelsong RJ, Bardes ES. 1992. 2-Bromopalmitoyl-CoA and 2-bromopalmitate: promiscuous inhibitors of membrane-bound enzymes. Biochim Biophys Acta 1125:203-209.
34. Tkacz JS, Lampen O. 1975. Tunicamycin inhibition of polyisoprenyl N-acetylglucosaminyl pyrophosphate formation in calf-liver microsomes. Biochem Biophys Res Commun 65:248-257.
35. Patterson SI, Skene JH. 1995. Inhibition of dynamic protein palmitoylation in intact cells with tunicamycin. Methods Enzymol 250:284-300.
36. DeJesus G, Bizzozero OA. 2002. Effect of 2-fluoropalmitate, cerulenin and tunicamycin on the palmitoylation and intracellular translocation of myelin proteolipid protein. Neurochem Res 27:1669-1675.
37. Hurley JH, Cahill AL, Currie KP, Fox AP. 2000. The role of dynamic palmitoylation in Ca2+ channel inactivation. Proc Natl Acad Sci USA 97:9293-9298.
38. Li L, Haynes MP, Bender JR. 2003. Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. Proc Natl Acad Sci USA 100:4807-4812.
39. Lawrence DS, Zilfou JT, Smith CD. 1999. Structure-activity studies of cerulenin analogues as protein palmitoylation inhibitors. J Med Chem 42:4932-4941.
40. Jochen AL, Hays J, Mick G. 1995. Inhibitory effects of cerulenin on protein palmitoylation and insulin internalization in rat adipocytes. Biochim Biophys Acta 1259:65-72.
41. De Vos ML, Lawrence DS, Smith CD. 2001. Cellular pharmacology of cerulenin analogs that inhibit protein palmitoylation. Biochem Pharmacol 62:985-995.
42. Omura S. 1976. The antibiotic cerulenin, a novel tool for biochemistry as an inhibitor of fatty acid synthesis. Bacteriol Rev 40:681-697.
43. Kawaguchi A, Tomoda H, Okuda S, Awaya J, Omura S. 1979. Cerulenin resistance in a cerulenin-producing fungus. Isolation of cerulenin insensitive fatty acid synthetase. Arch Biochem Biophys 197:30-35.
44. Vance D, Goldberg I, Mitsuhashi O, Bloch K. 1972. Inhibition of fatty acid synthetases by the antibiotic cerulenin. Biochem Biophys Res Commun 48:649-656.
45. Nomura S, Horiuchi T, Hata T, Omura S. 1972. Inhibition of sterol and fatty acid biosyntheses by cerulenin in cell-free systems of yeast. J Antibiot (Tokyo) 25:365-368.
46. Price AC, Choi KH, Heath RJ, Li Z, White SW, Rock CO. 2001. Inhibition of beta-ketoacyl-acyl carrier protein synthases by thiolactomycin and cerulenin. Structure and mechanism. J Biol Chem 276:6551-6559.
47. Ducker CE, Griffel LK, Smith RA, Keller SN, Zhuang Y, Xia Z, Diller JD, Smith CD. 2006. Discovery and characterization of inhibitors of human palmitoyl acyltransferases. Mol Cancer Ther 5:1647-1659.